Sökning: (WFRF:(Cruchaga C.)) srt2:(2011) >
Fine mapping of gen...
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.
-
Kauwe, John S K (författare)
-
Cruchaga, Carlos (författare)
-
Karch, Celeste M (författare)
-
visa fler...
-
Sadler, Brooke (författare)
-
Lee, Mo (författare)
-
Mayo, Kevin (författare)
-
Latu, Wayne (författare)
-
Su'a, Manti (författare)
-
Fagan, Anne M (författare)
-
Holtzman, David M (författare)
-
Morris, John C (författare)
-
Goate, Alison M (författare)
-
- Blennow, Kaj, 1958 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
-
visa färre...
-
(creator_code:org_t)
- 2011-02-09
- 2011
- Engelska.
-
Ingår i: PloS one. - : Public Library of Science (PLoS). - 1932-6203. ; 6:2
- Relaterad länk:
-
https://journals.plo...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Recent genome-wide association studies of Alzheimer's disease (AD) have identified variants in BIN1, CLU, CR1 and PICALM that show replicable association with risk for disease. We have thoroughly sampled common variation in these genes, genotyping 355 variants in over 600 individuals for whom measurements of two AD biomarkers, cerebrospinal fluid (CSF) 42 amino acid amyloid beta fragments (Aβ(42)) and tau phosphorylated at threonine 181 (ptau(181)), have been obtained. Association analyses were performed to determine whether variants in BIN1, CLU, CR1 or PICALM are associated with changes in the CSF levels of these biomarkers. Despite adequate power to detect effects as small as a 1.05 fold difference, we have failed to detect evidence for association between SNPs in these genes and CSF Aβ(42) or ptau(181) levels in our sample. Our results suggest that these variants do not affect risk via a mechanism that results in a strong additive effect on CSF levels of Aβ(42) or ptau(181).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Psykiatri (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Psychiatry (hsv//eng)
Nyckelord
- Adaptor Proteins
- Signal Transducing
- genetics
- Aged
- Aged
- 80 and over
- Alzheimer Disease
- cerebrospinal fluid
- genetics
- Amyloid beta-Peptides
- cerebrospinal fluid
- Biological Markers
- cerebrospinal fluid
- Clusterin
- genetics
- Female
- Genetic Predisposition to Disease
- genetics
- Humans
- Male
- Middle Aged
- Monomeric Clathrin Assembly Proteins
- genetics
- Nuclear Proteins
- genetics
- Peptide Fragments
- cerebrospinal fluid
- Phosphorylation
- Polymorphism
- Single Nucleotide
- Receptors
- Complement 3b
- genetics
- Serine
- metabolism
- Tumor Suppressor Proteins
- genetics
- tau Proteins
- cerebrospinal fluid
- chemistry
- metabolism
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
PloS one
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Kauwe, John S K
-
Cruchaga, Carlos
-
Karch, Celeste M
-
Sadler, Brooke
-
Lee, Mo
-
Mayo, Kevin
-
visa fler...
-
Latu, Wayne
-
Su'a, Manti
-
Fagan, Anne M
-
Holtzman, David ...
-
Morris, John C
-
Goate, Alison M
-
Blennow, Kaj, 19 ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Psykiatri
- Artiklar i publikationen
-
PloS one
- Av lärosätet
-
Göteborgs universitet